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Abstract
Prader-Willi syndrome (PWS) is the leading genetic cause of obesity. After initial severe hypotonia, PWS children become
hyperphagic and morbidly obese, if intake is not restricted. Short stature with abnormal growth hormone secretion,
hypogonadism, cognitive impairment, anxiety and behavior problems are other features. PWS is caused by lack of
expression of imprinted genes in a ,4 mb region of chromosome band 15q11.2. Our previous translocation studies
predicted a major role for the C/D box small nucleolar RNA cluster SNORD116 (PWCR1/HBII-85) in PWS. To test this
hypothesis, we created a ,150 kb deletion of the .40 copies of Snord116 (Pwcr1/MBII-85) in C57BL/6 mice. Snord116del
mice with paternally derived deletion lack expression of this snoRNA. They have early-onset postnatal growth deficiency,
but normal fertility and lifespan. While pituitary structure and somatotrophs are normal, liver Igf1 mRNA is decreased. In
cognitive and behavior tests, Snord116del mice are deficient in motor learning and have increased anxiety. Around three
months of age, they develop hyperphagia, but stay lean on regular and high-fat diet. On reduced caloric intake, Snord116del
mice maintain their weight better than wild-type littermates, excluding increased energy requirement as a cause of
hyperphagia. Normal compensatory feeding after fasting, and ability to maintain body temperature in the cold indicate
normal energy homeostasis regulation. Metabolic chamber studies reveal that Snord116del mice maintain energy
homeostasis by altered fuel usage. Prolonged mealtime and increased circulating ghrelin indicate a defect in meal
termination mechanism. Snord116del mice, the first snoRNA deletion animal model, reveal a novel role for a non-coding RNA
in growth and feeding regulation.
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Introduction
As the leading genetic cause of obesity with a prevalence of 1 in
10,000 to 20,000, Prader-Willi syndrome (PWS) is a complex
neuro developmental disorder characterized by neonatal hypoto-
nia and failure to thrive, developmental delay, cognitive defects,
hypogonadotropic hypogonadism, characteristic facial features,
short stature, and behavioral abnormalities [1]. The most
prominent feature of PWS is hyperphagia with an age of onset
between 2 and 6 years, which if uncontrolled, can lead to morbid
obesity and associated ailments that include type 2 diabetes,
cardiovascular disease and early death [2]. The underlying
mechanism of the hyperphagic behavior is unclear. PWS is caused
by the inactivation or deletion of several imprinted, paternally
expressed genes within 4 Mb of chromosome band 15q11.2 [3].
Molecular mechanisms include large deletions, maternal unipa-
rental disomy for chromosome 15 or mutations involving the
imprinting center. The current challenge in PWS research is to
elucidate the contributions of individual loci to the genetic and
molecular pathways that are affected, leading to PWS-associated
phenotypes. Prior studies of spontaneous reciprocal translocations
and deletions allowed us to narrow down the critical region within
the common deletion interval to ,121 kb [4,5]. Within this
interval resides a novel paternally expressed imprinted gene
cluster, SNORD116@ (the current approved gene symbol for
PWCR1/HBII-85 in human, GeneID: 692236, and Pwcr1/MBII-
85 in mouse, GeneID: 64243) that encodes multiple copies of a
small nucleolar RNA (snoRNA) with short conserved sequence
elements, called C and D boxes [6–8]. SNORD116 in human, and
Snord116 in mouse, were the first mammalian snoRNA genes
discovered to show uniparental (imprinted) expression. There are
27 copies of SNORD116 in humans and more than 40 copies of
Snord116 in mice. These snoRNAs are located in introns of a ‘‘host
gene’’ that is made up of non-coding (in human) exons of the large
SNRPN transcript. Individual snoRNA molecules are generated
during the pre-mRNA splicing process [9]. While the 96 bp
snoRNA sequences are largely conserved between humans and
mice, the host gene exons are not [6,8]. The mouse build 37
genome database lists 41 copies, 26 of which have been mapped in
regular intervals to three contigs on mouse chromosome band 7C,
and the other 15 are not mapped, indicating that the genomic
sequence in this region is still incomplete.
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usually serve to direct the site-specific methylation of the ribose 29-
hydroxyl group of specific nucleotides in ribosomal RNA (rRNA)
or small nuclear RNA (snRNA) by base-paring with the target
sequences [10]. SNORD116 belong to a novel class of snoRNAs,
expressed most highly in brain in humans and exclusively in brain
in mouse. Their putative target recognition sites are not
complementary to any known rRNA, tRNA or snRNA sequences,
and their biological targets are unknown.
In addition to SNORD116, there are several other C/D box
snoRNAs in the interval between SNRPN (small nuclear
ribonucleoprotein N, GeneID: 6638) and UBE3A (ubiquitin-
protein ligase E3A, GeneID: 7337) in the PWS deletion region
[4,7,9]. Another cluster of C/D box snoRNA, SNORD115@
(formerly known as HBII-52, GeneID: 692218) is located
downstream of SNORD116 in both human and mice (Fig. 1A).
SNORD115 has a target binding sequence complementary to
serotonin receptor 2C pre-mRNA, and has been reported to
influence the regulation of alternative splicing [11]. The lack of
PWS phenotypes in individuals or mice lacking SNORD115
expression, however, excluded these snoRNAs as candidate genes
for PWS [4,12,13]. Three single-copy snoRNAs, SNORD107
(HBII-436,GeneID: 91380), SNORD64 (HBII-13 GeneID:
347686), and SNORD108 (HBII-437, GeneID: 338427) are located
upstream of SNORD116 and were also excluded from playing a
role in PWS [5]. In the human genome, there are two copies of
SNORD109 (HBII-438), one located upstream of SNORD116
(SNORD109A, GeneID: 338428) and the other downstream of
SNORD115 (SNORD109B, GeneID: 338429). We were unable to
identify a mouse homolog of SNORD109. Therefore, lack of
expression of the SNORD116 cluster is most likely responsible for
many aspects of PWS.
The PWS deletion region is conserved on mouse chromosome
7C. Prior mouse models for PWS include three different strains of
deletion mice that affect expression of multiple genes including the
snoRNA region. Imprinting-center (IC) deletion mice [14] and
mice with a transgene-induced 6.8 Mb genomic deletion that
includes the mouse equivalent of the entire PWS region [15,16]
lack expression of multiple genes and die soon after birth.
Occasional survivors with the IC deletion on a hybrid strain
background remain small, are fertile and do not become obese
[17]. While the knock-out of Snrpn alone has no abnormal
phenotype [14], a partial deletion of the PWS orthologous region,
extending from Snrpn to Ube3a, removes the expression of the Snrpn
coding transcript and of all the paternally expressed non-coding
elements in between Snrpn and Ube3a [18]. These mice suffer
severe postnatal growth retardation, and 80% die before weaning.
Survivors grow to adulthood without obvious defects, despite their
smaller size, and do not develop obesity. No metabolic or
behavioral studies of these mice have been reported. The high
lethality rate in young pups makes phenotypic characterization of
adult mice difficult.
In this study, we test the hypothesis that the SNORD116
snoRNA cluster is the major contributor to the PWS phenotype.
To elucidate the role of this snoRNA, we created a new mouse
model for PWS by deleting all the copies of Snord116. Mice with
paternally inherited Snord116 deletions have striking growth delay
in the first three postnatal weeks, but no lethality, which enabled us
to carry out multiple neurobehavioral and metabolic tests.
Snord116 deletion mice have normal muscle strength but a defect
in motor learning. Adult mice have hyperphagia, elevated levels of
plasma ghrelin and altered metabolism, but normal energy
homeostasis regulation. Based on our results, we propose that
the key defect underlying the hyperphagic behavior in PWS is not
defective regulation of energy homeostasis as had been proposed
[19,20], but rather defective control of meal termination. This is
the first in vivo study of the biological function of a snoRNA in a
vertebrate system, and we report the function of this imprinted C/
D box snoRNA on early postnatal growth, motor learning and
feeding regulation.
Results
Creation of the Snord116del mouse model
To generate mice deleted for the imprinted Snord116 snoRNA
cluster, we used two chromosome-engineering strategies in
parallel, with Cre-mediated deletion either in vivo in the ovary,
or in cultured male embryonic stem (ES) cells. First, we cloned the
genomic sequences from mouse bacterial artificial chromosomes
(BAC) RP23-371M8 and RP23-309E15 and made two targeting
constructs flanking the Snord116 cluster (Fig. 1A). By homologous
recombination in BRUCE4 ES cells (derived from male blastocysts
of the C57BL/6 strain), we inserted two cassettes with loxP sites
and drug resistance markers flanked by different Frt sites,
upstream and downstream of the Snord116 cluster (Fig. 1A,B).
To obtain 2-loxP ES cells, we deleted the drug resistance markers
by transfecting the doubly resistant ES cells with a vector
expressing Flp recombinase. To derive 2-loxP mice, 2-loxP ES
cells were injected into C57Bl/6J –Tyr
c-2J/J albino blastocysts and
three male chimeric mice were obtained, with 20–80% ES cell
origin based on coat color, all of which transmitted the modified
allele through the germ-line. The 2-loxP mice with a paternally
derived modified allele were indistinguishable from their wild-type
(WT) littermates.
Heterozygous 2-loxP mice were mated to a transgenic strain
expressing Cre recombinase under the control of the ovary-specific
Zp3 promoter on a C57BL/6J background. When we mated
doubly heterozygous (2-loxP/+; Zp3-Cre/+) females with WT
C57BL/6J males, we obtained six 1-loxP mice among 20
offspring. The presence of the large deletion was documented by
Southern blot (data not shown) and confirmed by PCR
amplification of a small product, of expected size and sequence,
with primers spanning the ,150 kb genomic region that is deleted
(Fig. 1C).
In the second approach, we generated 1-loxP ES cells with the
,150 kb deletion by transfecting doubly-targeted ES cells with a
Cre recombinase expressing vector. We obtained two male
chimeric mice, with 10% and 40% 1-loxP ES-cell derived coat
color, respectively, but only the higher-level chimera passed the
deletion allele through the germ-line. The 1-loxP mice derived
either from 1-loxP ES cells or from the mating of the 2-loxP/Zp3-
cre mice exhibited the same degree of growth retardation when
the deletion allele was paternally inherited.
Expression of genes in PWS critical region (PWCR)
The ,150 kb Snord116 deletion could potentially change the
chromatin conformation of the flanking region or remove regu-
latory elements and, thus, affect the expression of neighboring
genes. To examine this possibility, we measured the expression of
gene elements in the region by quantitative RT-PCR of brain
samples (Fig. 1D). Compared to WT levels, expression of the up-
stream snoRNA Snord107 was decreased by 3566% (P,0.0005),
and that of the downstream Snord115 (MBII-52) snoRNA cluster
was increased by 3368% (P,0.01). Expression of gene elements
located further upstream, Ndn (Necdin, GeneID: 17984) and Snrpn,
or downstream (Ube3a) was unchanged. Although Ube3a is
expressed exclusively from the maternal allele in brain and,
therefore, should not be affected by the Snord116 deletion on the
paternal chromosome, a reduction of the paternal-specific
SnoRNA Deletion Mouse and PWS
PLoS ONE | www.plosone.org 2 March 2008 | Volume 3 | Issue 3 | e1709Figure 1. Derivation of Snord116 (Pwcr1/MBII-85) deletion mice. A. Genomic region and structure of targeting constructs (not to scale). Top:
Location of BACs used for making constructs. Middle: Map of Prader-Willi syndrome critical region (Pwcr) on mouse chromosome 7C. Gray thin line with
arrowhead, large transcript originating from the Snrpn promoter; short black bars, coding exons for Snrpn on the left, and for Ube3a on the right; short
gray bars, non-coding exons; high black bars, snoRNAs (not representing accurate numbers of elements in clusters, there are at least 41 copies of
Snord116). Bottom: Left, upstream construct; right, downstream construct. Thick lines represent mouse genomic sequence, and thin lines vector
sequence. Black arrowheads, loxP sites; white arrowheads, Frt1 sites; grey arrowheads, Frt 5 sites. Neo, Puro, TK and DT boxes indicate location of PGK-
Neo
r, PGK-Puro
r , HSV-TK and diphtheria toxin selection markers. Positions and direction of the genotyping primers PA, PB, PC and PD are indicated. B.
Southern blots of targeted ES cell clones with probes from outside the targeting constructs. Lanes 1 and 2, NcoI digests were hybridized with probe UL
located upstream of the upstream targeting construct. Lane 1, wild-type ES cells (WT); lane 2, a recombinant ES cell clone (B41) targeted with the
upstream construct. The WT allele generates a 19.5 kb band, and the recombinant fragment is 9.5 kb. Lanes 3-6, Stu1 digested DNA was probed with
probe DR located downstream of the downstream targeting construct. Lanes 3 and 5, clone B41; lane 4, C1, a recombinant clone after transfecting B41
with the downstream targeting construct; lane 6, clone D1, derived from C1 after Cre recombinase-mediated recombination. The WT allele, represented
by the upstream targeted clone B41, generates a band of .16 kb, and the recombinant fragments are6.5 kb in C1 (a doubly-targeted 2-loxP clone) and
10 kb in D1 (a 1-loxP clone with the ,150 kb deletion), respectively. C. Genotyping of 1-loxP ES cells by multiplex PCR with primers PA, PC and PD. The
WT band is 435 bp, the amplification product of primers PC and PD; and the deleted allele is 327 bp, a product of amplification between PA and PD.
Lanes 1 and 2 represent two clones after Cre mediated deletion (D1 and D5); Lane 3, wild-type ES cells; lane 4, doubly targeted 2-loxP ES cell clone (C1).
H2O: notemplatenegativecontrol;MW: molecular weight marker. D. Quantitativereal-timeRT-PCRstudy forexpression of geneelements in PWS critical
region. DNaseI treated total brain RNA from 4-week old mice (n=9 WT, 7 Del) was used as template for qRT-PCR assays. Each sample was assayed in
triplicate. Gapdh expression was used as internal control. The levels for each sample are normalized to the average of the WT samples. Error bars,
standard error of the mean (SEM). Asterisks indicate significant differences; for Snord64, P,0.0005; Snord116, P,1 610
27, and Snord115, P,0.01.
doi:10.1371/journal.pone.0001709.g001
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the paternal Ube3a allele and, thus, change its transcript level. As
expected, the expression of Snord116 was completely abolished,
confirming that we have successfully removed all copies of this
snoRNA.
Postnatal growth deficiency and reduced IGF-I
We observed severe postnatal growth retardation in mice with
paternally inherited Snord116 deletion (Fig. 2). Mice with maternal
inheritance of the Snord116 deletion grew normally (data not
shown), consistent with the fact that the Snord116 cluster is
imprinted and the maternal copies are silenced. From now on,
‘‘deletion mice’’, ‘‘Snord116del mice’’ or ‘‘mutant mice’’ refer to
mice with a paternal deletion.
At prenatal stages E12.5, E14.5 and E18.5, the mutant embryos
and placenta were of normal size (data not shown). At birth,
deletion mice were also indistinguishable from WT. As of
postnatal day 2 (P2), however, they failed to gain weight as
effectively as their WT littermates, and by 3 weeks of age, the
mutants’ weight was ,60% of the WT weight for males (Fig. 2A,
left) and females (not shown). Although the mutants’ rate of growth
appeared to normalize after weaning, the weight differences
persisted to adulthood for both genders (Fig. 2A, middle and right).
The length of the mutant mice was also decreased. At 5 months of
age, the length of the mutant males was 95.860.4% of WT (n=13
WT, 9 Del, P,1610
26), and the length of the mutant females was
97.660.8% of WT, (n=12 WT, 12 Del, P,0.05), as measured
under anesthesia from the tip of the nose to the anus. Unlike
previously reported PWS mouse models with neonatal lethality,
almost all the Snord116del mice survived to adulthood, and appear
healthy at their current age of 18 months.
Possible causes of the striking early postnatal growth failure
include reduced milk intake. Human neonates with PWS have
severe hypotonia and are unable to suck effectively, so that gavage
feeding is usually required. In a previous mouse model for PWS,
decreased milk intake and impaired righting ability from the prone
position had been reported [18]. In contrast, we observed
sufficient milk in the stomachs of young pups with Snord116
deletion when their abdomens were still transparent. Also, the
mutant pups were not hypotonic. When tested at P5, they
accomplished the righting task with equal or better efficiency than
their WT littermates, and they could hold on to a 45 degree rough
surface longer than the WT littermates (data not shown). A careful
dissection at P5 and P13 showed strikingly reduced sizes of liver
(72615% of WT at P5 and 5662% at P13; both P,0.0001), and
stomach (67636% at P5 and 6866% at P13; P,0.05 and
P=0.05, respectively), but brain weights were only slightly
decreased (9567% of WT at P5, and 9261% at P13; both
P,0.02) (Fig. 2B). The disproportionately small stomach size at P5
may suggest that reduced food intake could contribute to the
growth retardation. We also observed decreased subcutaneous fat
storage during the dissection. Histologic examination of H & E
stained sections of all other inner organs, including the brain,
revealed no apparent abnormalities in the Snord116del mice
compared to WT littermates.
Since individuals with PWS have short stature after early
childhood that is in part due to growth hormone (GH) deficiency,
and the growth retardation of Snord116del mice persisted to
adulthood, we measured the direct downstream effector of GH
action, the transcript levels of insulin-like growth factor (Igf1,
GeneID: 16000) in liver. By performing quantitative RT-PCR
with liver RNA samples from 4-wk and 8-wk old mice, we found
that Igf1 mRNA expression was significantly lower in the mutants
at both time points, 7668% of the WT level at 4 wk and 8068%
at 8 wk (both P,0.04) (Fig. 2C left). Measurements of circulating
IGF-I protein in serum showed an even more drastic reduction to
3965% of the WT level at 4 wk and 5766% at 8 wk (both
P,0.0005) (Fig.2C right). These results indicate involvement of
the GH pathway in the reduced growth of the mutants.
Normal structure and development of pituitary
Since we observed a reduction in liver Igf1 mRNA expression
and in circulating levels of IGF1 protein, indicative of GH
deficiency, and since most individuals with PWS are GH deficient,
we studied the structure and development of the pituitary gland to
determine whether the GH deficiency is caused by a structural
pituitary defect or a reduction in the number of GH producing
cells in the anterior pituitary. We performed H&E staining of
E12.5, E14.5 and E18.5 embryonic and adult (4 week old)
pituitaries. The developing pituitary gland appeared morpholog-
ically normal in sections from Snord116del embryos (Fig. 2D). To
obtain quantitative data, we determined the volume of the
pituitary gland at E18.5 and at 4 wk by using three-dimensional
reconstruction. The volume of the pituitary gland was not
significantly reduced in E18.5 Snord116 embryos compared to
their WT littermates. For example, at E18.5 pituitary volume was
5.1660.8610
6 A.U.
3, (n=3 WT) compared to 5.060.9610
6
A.U.
3 (n=3 Del). In adult Snord116del mice (n=3), the volume of
the pituitary gland was also not significantly reduced, relative to
body weight (data not shown).
Given that the morphology of the Snord116 pituitary was
normal, we asked whether the GH deficiency observed could be
due to a reduction in hormone-producing cells in the anterior
pituitary. To address this question, we performed immunohisto-
chemical staining for the five hormone-producing cell types
present in the anterior pituitary. This analysis revealed that all
cell types are present in normal proportions in the developing
(E18.5) and adult (P28) Snord116 pituitary compared to the WT
(Supplementary Figure S1). With no reduction in the number of
GH-producing cells (somatotrophs, Fig. 2E) and apparently
normal immunogenicity of the GH protein in these cells, the
cause of GH-deficiency most likely resides in the regulation of GH
release.
Normal fertility and delayed sexual maturation
Individuals with PWS have hypoplastic genitalia, and delayed
and often incomplete sexual maturation, secondary to deficiency
of gonadotropic hormones. In Snord116del mice, the sizes of testes
and ovaries were proportional to their body size and histologically
normal. The fertility of male and female mutant adults was
normal. The males consistently plugged their female partners, and
the females gave birth to litters of 4–8 pups almost every month
until 12 months of age, when the mating was stopped. This
breeding profile is typical of C57BL/6 mice [21]. As an indicator
of sexual maturation, we studied the timing of vaginal opening in
Snord116del females and WT littermates. In the mutants, vaginal
opening was delayed by 3.660.7 days (n=39 WT, 27 del,
P,0.001). These results indicate delayed sexual maturation,
consistent with the human PWS phenotype.
Increased anxiety and normal working/spatial memory
People with PWS have developmental delay, motor and
cognitive deficits, as well as anxiety and behavioral abnormalities.
We, therefore, subjected Snord116del mice and their WT
littermates to a battery of neurobehavioral test at 2–6 months of
age.
In the Open Field test, a measure of exploratory behavior and
general anxiety, we detected no difference between the deletion
SnoRNA Deletion Mouse and PWS
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rearing and grooming, time spent in the inner square, and
frequencies of urination and defecation (data not shown). When
tested in the Elevated Plus Maze at 3–4 months of age, the
deletion mice made more entries into the closed arms (7763%
WT, 8662% Del, P,0.02), and spent more time in the closed
Figure 2. Growth and somatic development of Snord116del mice. A. Daily weight curves for males (left) and weekly weight curves for males
(middle) and females (right). The female weight curve in the first month (not shown) overlaps with the male curve. Error bars, standard deviations.
Significant weight differences between Snord116del mice and their WT littermates ranged from P,0.05 in young pups, after postnatal day 2 (P2), to
P,1610
28 after 6 months (n=15,20 in each sex/genotype group). Insert photo: Snord116del (top) and WT (bottom) pups at P14. B. Comparison of
body and organ weights in Snord116del mice and WT littermates at P5 and P13 (P5: n=27 WT, 24 Del; P13: n=8 WT, 9 Del). Error bar: SEM. At P5, all
differences were significant at P,0.003 except for brain at P,0.02. At P13, all differences were significant at P,0.0001 except for stomach, P=0.05.
Bd: body, Br: brain, Lv: liver, St: stomach. C. Levels of Igf1 transcripts in liver and IGF-I protein in serum are reduced in deletion mice. Left: Liver RNA
from 4-week old (n=9 WT, 7 Del) and 8-week old (n=8 WT, 8 Del) mice were assayed by qRT-PCR with Gapdh levels as internal control. WT levels
were set at 1. Error bar: SEM. Asterisks: P,0.05. Right: Serum levels of IGF-I protein from the same group of mice were measured by ELISA. Asterisks:
P,0.0005. D. Hematoxylin and eosin stained sagittal sections of the pituitary at E12.5 and E14.5 (left WT, middle Del) and coronal sections at E18.5
(right) revealed normal pituitary size and structure. E. Immunohistochemical staining for growth hormone (somatotrophs) revealed no detectable
differences in WT (top) and Del (bottom) mice at 4 weeks of age.
doi:10.1371/journal.pone.0001709.g002
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test with a different cohort of mice at a similar age (n=21 WT, 19
Del), and obtained the same results, with the deletion mice having
a significantly higher ratio of entries into the closed arms (7762%
WT, 8962% Del, P,0.0001) and a trend of longer times spent in
the closed arms (7663% WT, 8363% Del, P=0.08). These
results indicate that the Snord116del mice have an elevated level of
anxiety or fear.
To assess learning and memory of the Snord116del mice, we
measured their performance in the Y maze at 3 months of age.
The rates of spontaneous alternation were identical in the mutants
and their WT littermates, Del 5963% (n=17) and WT 5862%
(n=17), indicating no difference in short-term working memory.
For the novel arm preference test, we used a different cohort of
mice at 5 months of age. The Snord116del mice performed as well
as their WT littermates, with 4061% of entries into the novel arm
for the WT mice (n=9), and 4161% for the mutants (n=11).
These two types of results indicate that the Snord116del mice do not
have any obvious defect in working memory or spatial memory.
Normal motor function and defect in motor learning
To evaluate their muscle tone and strength, Snord116del mice
and their WT littermates were subjected to a wire-hanging test. To
our surprise, at 5 months of age, the mutants outperformed the
WT mice (Fig. 3B). While the latency to fall was 5267 sec for the
WT, the mutants were able to hold on for 114610 sec
(P,4610
25). At this age, however, the WT mice weighed
considerably more (30.760.6 g) than the mutants (25.060.4 g).
We, therefore, tested another cohort at 2 months of age. The
latencies were not significantly different: 90615 sec for WT and
116613 sec for mutant littermates (Fig. 3B); and the body weights
at 2 months were also more similar, with 24.460.7 g for WT and
21.060.5 g for mutants. We conclude that the Snord116del mice
are definitely not hypotonic, and that their reduced body weight
may have contributed to their better performance in the wire-
hanging test at 5 months of age.
To assess motor coordination and balance, as well as motor
learning, we measured the performance on an accelerating rotarod
at 2 and 5 months of age. We applied two trials per day for 6 days.
In the first trial on day 1, the 2 months old Snord116del mice
showed a similar level of performance as their WT littermates
(Fig. 3C), and at 5 months of age, they outperformed the WT mice
(P,0.004, data not shown). This is consistent with their
performance in the wire-hanging test at these ages. During the
six days of training, the WT mice at both ages improved
significantly. In contrast, the learning curves of the mutants
remained essentially flat, indicating that they have a motor
learning deficiency (Fig. 3C and data not shown).
Figure 3. Neurobehavioral tests of Snord116del and WT littermates. A. Elevated plus maze. Mice were tested at 3 months of age (n=15, both
genotypes). Left panel: Snord116del mice spent more time in the closed arms (P,0.05). Right panel: mutant mice made more entries to the closed
arms (P,0.02). B. Wire-hanging test. At 5 months of age, Snord116del mice were able to hang significantly longer than the WT littermates (P,5
610
25, n=17, both genotypes). At 2 months of age, the difference was not significant (n=13 WT, 9 Del). C. Rotarod test of balance and motor
learning. Mice were tested at 2 months (n=18 WT, 10 Del). Two trials were done on each day for 6 consecutive days. Asterisks indicate significant
differences between WT and deletion mice (P,0.05). All error bars are SEM.
doi:10.1371/journal.pone.0001709.g003
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Individuals with PWS have a higher pain threshold and
decreased pain sensitivity compared to unaffected controls [2].
To evaluate the nociception and response time to a painful
stimulus in 6-month old mice, we used a hot plate test. When
placed on a 52.5uC metal surface, mice of both genotypes had
identical response times. The WT mice (n=17) had a response
latency of 8.760.6 sec, and their Snord116del littermates (n=17)
had a latency of 8.860.6 sec. Thus, the Snord116 deletion did not
cause decreased sensitivity to thermal pain.
Feeding behavior and body composition on high-fat diet
Characteristically, individuals with PWS develop hyperphagia
at 2–6 years of age due to an obsession with food, which leads to
profound obesity and type 2 diabetes when their access to food is
not restricted. In contrast to the human PWS phenotype, the
Snord116del mice maintain a stable body weight as adults,
indicating proper feeding regulation under normal conditions.
We, therefore, studied their feeding behavior under different
challenges.
First, we measured their food intake on regular rodent chow
(14% calories from fat, 3.0 kcal/g). After one week of single
housing, food intake was measured for five consecutive days. The
7-week old Snord116del mice (D) and their WT littermates (W)
consumed the same amount of food in both dark and light phases,
when intake was normalized to body weight (Fig. 4A).
Next, we provided the mice with a high fat (HF) diet (45%
calories from fat, 4.73 kcal/g), and measured their food intake over
five consecutive days. Both the WT (HW) and Snord116del mice
(HD) reduced their total food intake on the HF diet (Fig. 4A).
Compared to their caloric energy intake on rodent chow, the WT
and deletion males adjusted their daily energy intake on HF food
to 104.462.4% and 94.661.6%, respectively, with the deletion
males consuming less than their WT littermates (2861.5%,
P,0.005). This difference is due to less daytime intake (P,0.006).
The females’ energy intake was not significantly different,
91.062.1% for WT and 97.162.5% for mutants. But like the
deletion males, the deletion females had lower intake in the light
phase (P,0.04) that was compensated by higher intake in the dark
phase of the daily cycle (P,0.03).
To determine whether long-term HF diet would result in
obesity, we kept the Snord116del mice and their WT littermates on
the HF diet from 8 weeks of age, and plotted their weight changes
during the next 4 months relative to the average weight at 7 weeks
of age (Fig. 4B). Both male and female deletion mice gained less
weight than the WT controls. Thus, they were relatively more
resistant to HF diet-induced obesity. The effect was more
pronounced in the mutant males, consistent with their lower
energy intake on HF diet as shown in Fig. 4A.
PWS is associated with high body fat mass and low muscle mass.
We measured total fat and lean body mass ratio in the Snord116del
mice by Dual Energy X-ray absorptiometry. After 4 months on
the HF diet, the Snord116del mice had significantly lower body fat
content than WT littermates (26.9%, P,0.0001 for males and
27.2%, P,0.02 for females) (Fig. 4C, HF). A cohort of mice kept
on regular rodent chow diet for 5 months, showed an insignificant
trend of lower fat content in deletion males compared to their WT
littermates (23.6%, P=0.07), and a significantly lower fat content
in deletion females (24.2%, P,0.02). A group of 9 months old
mice on regular rodent chow showed the same difference, with
significantly lower body fat content in deletion males (29%,
P,2610
27), and females (25%, P,0.02) (Fig. 4C). Taken
together, these results indicate that the Snord116 mice are leaner
that WT on a regular diet, as well as on a HF diet. The fact that
the Snord116del mice on HF diet have a higher body fat content
than those on the regular diet confirms that they are capable of
anabolic fat storage. Under both dietary regimes, however, the
overall fat storage is much lower in the mutant than in the WT
mice, which is contrary to the human PWS phenotype.
Finally, we assessed the ability to adjust food intake after fasting.
After a 24 hr fast, normal mice regain their pre-fasting body
weight within 48 hr due to compensatory hyperphagia. Some
obese strains, such as ob/ob (GeneID: 16846) mice or those with
neuronal ablation in the hypothalamic feeding circuit [22], have
abnormal weight regulation and are unable to compensate for
missed meals and to regain their body weight within 48 hr.
Therefore, we tested 3 months old Snord116del mice and their WT
littermates for their ability to compensate. After a 24 hr fast and
re-feeding, both the deletion and WT mice showed similar food
intake, as measured at 2, 4, 8, 12, 24, 48, and 72 hr after the
fasting period, and mice of both genotypes gained back the weight
they lost during fasting within 48 hrs (data not shown). When we
measured the 48 hr cumulative food intake, deletion males (M2)
showed a significantly higher compensatory intake, 3.0960.06
units of the pre-fasting daily intake, than the WT males, with only
2.8860.05 units of daily intake (P,0.02) (Fig. 4D). This difference
may reflect the known insufficient compensatory feeding of the
WT C57BL/6 males, which are prone to diet-induce obesity[23],
because it was not seen in females. The 48 hr cumulative food
intake for females (F2) was not significantly different, with WT and
deletion mice taking in 3.0760.05 units and 3.1460.06 units of
their pre-fasting daily intake, respectively. We conclude that
normal feeding regulation allows the Snord116del mice to restore
missed meals and maintain body weight with good precision.
Normal thermal regulation
In addition to abnormal re-feeding response to fasting, ob/ob
mice are also defective in thermal regulation. Within one hour of
exposure to a cold environment at 4uC, their core body
temperature drops by more than 3.5uC, and within 2–4 hours, it
reaches a dangerous range of hypothermia at ,27uC [24,25]. We
tested 5 month old WT and Snord116del mice for their ability to
maintain body temperature when placed in a 4uC room. The
deletion mice were able to keep their core body temperature for
the entire testing period of 32 hours (Fig. 4E), with the core
temperature of the deletion males roughly 0.5uC higher than that
of their WT littermates for most of the tested time points (P,0.05).
The deletion females were also able to keep their core body
temperature in the cold with slightly higher levels than the WT
(less than 0.5uC) at some testing points (data not shown). Given
their smaller size and lower body fat mass, the deletion mice may
require a slightly higher core temperature to maintain whole body
temperature. In summary, we conclude that the Snord116del mice
are capable of precise thermal regulation in the cold.
Insulin sensitivity is normal in females and increased in
males
Individuals with PWS and obesity may have insulin insensitivity,
but it is less pronounced than in subjects with simple obesity [26].
We performed glucose and insulin tolerance tests on 6 months old
mice after 4 months on HF diet, and on a similarly aged group on
regular diet. The female Snord116del mice and their WT littermates
showed no significant differences in their responses, either on the
HF or on the regular diet (data not shown). The Snord116del males
on the regular diet had the same level of basal blood glucose as
WT, but a lower peak after glucose injection (Fig. 5A). They also
responded more dramatically to insulin injection, indicating
increased insulin sensitivity (Fig. 5C). The deletion males on the
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PLoS ONE | www.plosone.org 7 March 2008 | Volume 3 | Issue 3 | e1709Figure 4. Feeding and energy homeostasis regulation of Snord116del mice and their WT littermates. A. Daily food intake and response to
High-Fat (HF) diet. The intake of rodent chow during the dark (black bars) and light cycles (open bars) were measured for five consecutive days at
7 weeks of age. Then, the mice were placed on HF diet, and their intake was measured daily for five consecutive days. Food intake was normalized to
average body weight during the five days of measurement. The daily intake on regular chow diet was not different between WT (W) and Snord116del
(D) mice. On HF diet, the daily intake of the deletion males (HD) was significantly lower than that of their WT littermates (HW) (P,0.005). This was
entirely due to decreased daytime intake. The deletion females on HF (HD) had lower intake in the dark (P,0.05), which was compensated by
increased daytime intake (P,0.05), so that their total daily intake was not different from their WT littermates (HW). (Males, n=16 WT, 16 Del; females
n=15 WT, 11 Del). B. Deletion mice gain less weight on HF diet. Eight-week old mice were put on HF for 4 months, and their body weight was
measured twice per week and plotted as the ratio to their weight prior to HF diet. Differences between male WT (MW, n=16) and male Snord116del
(MD, n=16) mice were significant at P,0.01 except for the first week on HF. Differences between female WT (FW, n=15) and female deletion (FD,
n=11) mice were significant at P,0.05 after 7 weeks on HF. C. Deletion mice have less body fat on regular and HF diet. Dual energy X-ray
absorptiometry was used to measure body composition of 5-months and 9-months old mice on rodent chow, and 6-months old mice that had been
on HF diet for 4 months. The differences between WT and Snord116del mice are all significant, except for the 5-months old males on chow. Males, at
5 months (n=13 WT, 9 Del; P=0.07); at 9 months (n=17, both genotypes, P,2 610
27); at 6 months after 4 months on HF diet (n=16, P,0.0001).
Females at 5 months (n=12, both genotypes, P,0.02), at 9 months (n=14 WT, 10 Del; P,0.007) and at 6 months after 4 months on HF diet (n=15
WT, 10 Del; P,0.02). D. Compensatory food intake after fasting. Mice at 3 months of age were fasted for 24 hr, and the ratio of their cumulative food
intake to their average pre-fasting daily intake was computed. M1 and M2, cumulative intake ratios of males in the first 24 and 48 hr (n=13 WT, 9
Del). F1 and F2, cumulative intake ratios of females in the first 24 and 48 hr (n=12). The deletion mice were able to compensate within 48 hr for the
missed feeding. The deletion males over-compensated compared to their WT littermates (P,0.02). E. Maintenance of body temperature in cold
environment. The core body temperature of 4 months old Snord116del (n=9) and WT (n=13) males in a 4uC cold room was measured with an anal
probe. The mutants were better able to maintain their core temperatures over extended time. Asterisks indicate P,0.05.
doi:10.1371/journal.pone.0001709.g004
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glucose injection (Fig. 5B), as well as a greatly increased sensitivity
to insulin (Fig. 5D). Taken together, the resistance to obesity of the
Snord116del males correlates with increased sensitivity to insulin.
Metabolic chamber studies reveal hyperphagia
To determine why the Snord116del mice are resistant to
developing obesity, we carried out more detailed analyses of their
feeding behavior and metabolism. We placed 6 months old
Snord116del males and their WT littermates into metabolic
chambers for 7 days. To our surprise, the mutant mice consumed
more food than their WT littermates after normalizing intake to
body weight (Fig. 6A). The water intake mirrored the food intake
with the deletion mice consuming more water as well (data not
shown). This result is apparently inconsistent with our previous
finding that 7 week old Snord116del mice had the same daily food
intake, after normalizing to body weight, as their WT littermates
when measured in their home cages (Fig. 4A). Suspecting that the
stress of the metabolic chambers could be the cause of the
observed difference, we placed the 6 months old mice that had
been tested in the chambers back into their home cages and
measured their food intake. We found that their daily food intake
was the same as during the last three days in the metabolic
chambers. The Snord116del males (n=21 WT, 19 Del) showed a
2263% increase in daily food intake normalized to weight
(P,2610
26). Deletion females at 6 months of age also had an
increased daily intake as measured in metabolic chambers, with a
seven day average of a 3264% increase after normalizing to body
weight (n=14 WT, 16 Del, P,3610
26). Taken together, these
data confirm that both male and female Snord116del mice are
hyperphagic at 6 month of age. When the details of their feeding
behavior were analyzed, the WT and deletion mice had a similar
number of feeding bouts during each light and dark cycle, but the
deletion mice had longer bouts, and, therefore, an extended total
feeding time (Fig. 6B).
We speculated that the hyperphagia detected in 6-month old
mutants could represent a failure to reduce food intake after the
rapid growth period, as the 7-week old mice were still growing and
had a higher ratio of food intake to body weight than older mice.
To evaluate a possible age effect, we measured food intake in 3-
month old mice in their home cages. Snord116del mice were
hyperphagic, but to a lesser degree than at 6 months, with an
increased daily food intake of 1363% (P,0.05) in males, and an
insignificant increase in females (4.362.6%) (Fig. 6C). When tested
at 10 months, both male and female Snord116del mice were
significantly hyperphagic (males 3165%, P,3610
25; females
Figure 5. Glucose and insulin tolerance tests of male mice. A. Glucose tolerance test (GTT) for mice on regular diet (RD) at 6 months of age.
Mice were injected with 1 g/kg glucose at time zero after 16 hr overnight fasting and serum glucose was measured for up to 2 h. n=13 WT, 9 Del).
Deletion mice were better able to clear the glucose that WT, P,0.05 at 30 min, and P,0.001 at 60 and 90 min time points). B. Glucose tolerance test
for mice after 4 months on HF diet (n=16) starting from 8 weeks of age (P,0.01 for all time points). C. Insulin tolerance test (ITT) for mice on regular
diet (RD) at 6 months of age. Wild type (n=13) and mutant (n=9) mice were injected with 1.6 U/kg insulin at time zero after 5 hr fasting from the
onset of the light cycle (P,0.05 at 60, 90 and 120 min). D. Insulin tolerance test for 6-months old mice after 4 months of HF diet. WT mice (n=15) and
deletion mice (n=16) were injected with 2 U/kg insulin (P,0.02 at time 0, and P,0.0002 at all other time points). Deletion males were more sensitive
to insulin than WT.
doi:10.1371/journal.pone.0001709.g005
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PLoS ONE | www.plosone.org 9 March 2008 | Volume 3 | Issue 3 | e1709Figure 6. Snord116del mice are hyperphagic and have altered metabolism. A. Daily food intake during 6 days in Oxymax metabolic
chambers was normalized to body weight (n=8 WT, 7 Del, all points P,0.05). Error Bars: SEM. B. Average feeding bout duration of the same group of
mice as in (A) during each 12 hr cycle. D, dark cycles; L, light cycles. Asterisks indicate P,0.05. C. Daily food intake at different ages. Daily food intake
was averaged over 5–7 consecutive days and normalized to body weight of each individual. At 7 week, males n=16 both genotypes; females, n=15
WT, 11 Del; at 3 months, males n=13 WT, 9 Del, P,0.04; females n=12 WT, 12 Del; at 6–7 months, (males n=15 both genotypes, P,2 610
26;
females n=14 WT, 16 Del, P,3 610
26, and at 10 months males n=21 WT, 19 Del, P,3 610
25; females n=13 both genotypes, P,2 610
25.D .
Oxygen consumption rates (averaged over 2 hr time periods) on the second and third day in the metabolic chamber (n=15 both genotypes). Bars at
bottom indicate light and dark cycles. Asterisks, P,0.05. E. Respiratory exchange rate (RER) averaged over 2 hr time periods for the same group of
mice as in (D) during the same time in the metabolic chamber. Asterisks, P,0.05. F. Weight change in mice food-restricted to 80% their normal daily
intake. Males (n=11 both genotypes) and females (n=13 both genotypes) at 11 months of age. Asterisks indicate significant difference between WT
and Del females with P,0.05. G. Snord116del mice have increased ghrelin levels. Plasma ghrelin levels were measured in ad lib fed mice at 11 months
of age (n=12 both genotypes; P,0.002) and 24 hr fasted mice (n=13 both genotypes ; P,0.0002)
doi:10.1371/journal.pone.0001709.g006
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25) (Fig. 6C). The results document the
development of hyperphagia after the initial period of growth
which resembles the behavior in PWS.
Elevated oxygen consumption and respiratory exchange
rates
While the Snord116 deletion mice ate more, they remained
smaller and leaner, raising questions about differences in energy
expenditure. The locomotor activities of the Snord116del mice and
their WT littermates were similar in the 7 day metabolic chamber
study, with mice of both genotypes showing higher initial activities
indicative of a normal response to a novel environment
(Supplementary figure S2). Their oxygen consumption rates,
however, showed a clear difference, with the deletion mice having
higher rates of oxygen consumption (Fig. 6D), part of which could
be attributed to altered fuel usage in Snord116del mice, as they had
a higher Respiratory Exchange Rate (RER) indicating more
carbohydrate and less fat usage (Fig. 6E).
The energy expenditure difference, however, cannot fully
account for the ,30% increase in food intake. Therefore, we
tested whether Snord116del mice truly need the ingested food by
restricting their intake to 80% of their normal intake levels. While
WT mice gradually lost weight, the Snord116del mice were better at
maintaining their weight, with females showing significant and
males showing a trend of improved weight stability (Fig. 6F). We
concluded that the hyperphagia in Snord116del mice is not simply
due to increased energy requirement.
Increased circulating ghrelin level
Human PWS individuals have increased circulating levels of
ghrelin, a potent orexigenic peptide, which is thought to contribute
to their hyperphagic behavior. We, therefore, asked whether the
deletion of the Snord116 cluster in mice causes abnormal secretion
of ghrelin as well. As shown in Fig. 6G, ghrelin levels in adult
Snord116del mice with ad libitum access to food are increased to
2.360.3 fold compared to WT level (P,0.002). This increased
level is similar to that seen in normal mice after 24 hr fasting. The
deletion mice showed a normal response to fasting, i.e. a
proportional increase to 2.860.3 fold of the fasted WT level
(P,0.0002). Our finding of increased circulating ghrelin in the
Snord116del mice provides a molecular handle towards further
dissection of the hyperphagia phenotype.
Discussion
In our attempt to dissect the PWS deletion region and identify
individual genes that contribute to the phenotype, we focused on
the previously implicated snoRNA cluster Snord116 (Pwcr1/MBII-
85) and created a mouse model that is deleted for this snoRNA
cluster. The deletion mice recapitulate a subset of the PWS pheno-
type, such as postnatal growth retardation, delayed sexual matura-
tion, increased anxiety, motor learning deficit, hyperphagia and
hyperghrelinemia (Table 1). PWS features that are lacking include
hypotonia, obesity and decreased sensitivity to pain. The differ-
ences between humans and mice could be species-specific, or other
genes could be involved in combination with the Snord116 cluster.
In this first deletion mouse model for any snoRNA, we identified
specific defects in early postnatal growth, feeding behavior and
metabolic fuel usage that might provide insight into the
pathophysiology of PWS and mechanisms of obesity in general.
Is the lack of Snord116 causing the observed phenotypes?
The deletion of ,150 kb of genomic DNA could alter the
expression of neighboring or distant loci, for example, by changing
the chromatin conformation of the flanking region, or by deleting
enhancer/repressor elements or unidentified miRNAs. We have
evidence that the observed phenotypes are not due to changes in
the expression of nearby genes. First, the expression levels for the
closest protein coding genes, Ndn (necdin), Snrpn, and Ube3a in
brain were not changed in quantitative real-time RT-PCR assays.
Second, a large-scale gene expression profiling study using
Illumina microarrays also revealed no changes in transcript levels
of nearby protein coding genes and expressed sequence tags (data
not shown). Therefore, the Snord116 deletion does not affect the
expression of flanking protein-coding genes in the PWS critical
region (PWCR).
The PWCR contains many other snoRNA genes. In the human
PWCR, the transcription unit of SNURF-SNRPN includes all the
intron-encoded snoRNAs in a single large RNA precursor [9]. A
similar large transcript was recently identified in mouse [27].
Therefore, the Snord116 deletion could affect the processing
efficiency of intronic elements that are located upstream or
downstream of the deletion breakpoints. Such a mechanism might
explain the small decrease in Snord107 expression and the small
increase in Snord115 expression that we observed in the brain of
Snord116del mice. In previous studies, however, SNORD107 and
SNORD115/Snord115 were excluded from contributing to the
PWS phenotype in humans and mice (see Introduction).
Therefore, it is unlikely that the subtle changes in the levels of
these snoRNAs could be causing the major phenotypes in
Snord116del mice.
Experimental proof that loss of a specific gene is responsible for
a certain phenotype is straightforward for single-copy genes, where
a point mutation can be made to abolish gene function without
affecting the genomic structure. The fact that Snord116 exists as a
gene cluster of at least 41 copies and spans ,150 kb of genomic
DNA precludes such an experiment. Alternatively, one could test
whether a transgene expressing Snord116 corrects the abnormal
phenotype of the deletion mice. We made several transgenic
mouse strains expressing Snord116 from a neural-specific enolase
promoter and achieved Snord116 expression levels comparable to
that of an endogenous single-copy gene. Expression from our
transgene construct, which contains a single copy of Snord116
within nucleolin intron 11[28], is comparable to that of an average
endogenous single-copy gene, but far lower than the endogenous
level of Snord116 expressed from the .40-copy cluster (data not
shown). Consequently, the transgenes failed to rescue the neonatal
growth retardation and lethality present in Snrpn to Ube3a deletion
mice [18]. To achieve a higher level of Snord116 expression, as
may be required for transgenic rescue, the creation of BAC
transgenics might be an option which, however, would face the
risk of introducing unrecognized genetic elements such as
miRNAs.
As for the possibility of an unidentified gene or genes in the
deleted interval being responsible for the observed phenotypes, we
were unable to identify any conserved elements other than the
multiple copies of Snord116 in the deleted interval. The exons of
the host gene, which in mouse encode an open reading frame
(hypothetical protein LOC664788), are not conserved in human.
Our conclusion that the Snord116 deletion is responsible for the
phenotypes in the mice is supported by a recently presented
individual with PWS who has a paternally derived small genomic
deletion comprising the entire SNORD116 cluster and half of the
SNORD115 cluster. SNORD116 expression was completely abol-
ished (Sahoo T, del Gaudio D, German JR, Shinawi M, Peters
SU, Person R, Garnica A, Cheung SW, Beaudet AL, Prader-Willi
syndrome is caused by paternal deficiency for the HBII-85 C/D
box snoRNA cluster. Presented at the annual meeting of The
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Causes of postnatal growth retardation
Human infants with PWS have severe central hypotonia which
makes them unable to suck effectively, and special feeding devices
are often required. But despite adequate nutrition, they fail to
thrive during infancy. Older children and adults with PWS have
short stature in part due to growth hormone (GH) deficiency and
respond well to GH treatment [29–31].
The Snord116del mouse model reproduces the severe neonatal
growth retardation, but not the hypotonia. We were unable to
document reduced milk intake, although stomach weights at P5
were reduced. Thus, it remains possible that a subtle difference in
suckling behavior reduces milk intake, and cumulatively affects
growth. Growth hormone secretion is not required during the first
two weeks after birth, as shown by the normal growth in the first
two weeks of the GH receptor knock-out mice [32]. Therefore, the
neonatal growth retardation in Snord116del mice must be due to a
defect other than lower GH secretion. The persistent growth
retardation in puberty and adulthood in the deletion mice,
however, is consistent with GH deficiency. No obvious difference
in pituitary size or the number of GH producing cells was evident
around the time of birth or in 4-week old mutants. Since GH
secretion is pulsatile and the half-life of GH is very short (about
15–20 min), it can be difficult to demonstrate reduced circulating
levels. To obtain a reliable assessment, we evaluated GH activity
by measuring the mRNA and protein levels of IGF-I (insulin-like
growth factor 1) and documented reduced Igf1 mRNA levels in
liver, as well as reduced IGF1 protein levels in the serum, at 4 and
8 weeks of age. Since Igf1 transcription increases in response to
GH binding, these results indicate an abnormality in GH release
and/or signaling in the deletion mice. Our findings in the
Snord116del mice are consistent with decreased circulating IGF-I in
both GH-receptor (GeneID: 14600) and hypothalamic growth
hormone-releasing hormone (GHRH) receptor (GeneID: 14602)
deficient mice, that are approximately half and two-thirds the
weight of their WT littermates, respectively [33–35] . Notably,
circulating IGF-I levels in the GHRH (lit/lit) mice are in the range
seen in our Snord116del mice (data not shown) suggesting a
common final mechanism for the growth retardation related to
available circulating IGF-I.
The literature on PWS has long suspected that the primary
defect lies in hypothalamic dysfunction. While early autopsies of
PWS brains revealed a reduction in the size of the paraventricular
nucleus containing fewer oxytocin-preducing neurons and a 30%
reduction in GHRH-producing neurons in the nucleus arcuatus of
the hypothalamus [36], more recent studies of hypothalami from
six adult obese PWS individuals did not confirm a reduction of
GHRH-neurons [37]. Furthermore, GHRH and gonadotropin
stimulation studies in humans demonstrated a lack of response in
Table 1. Phenotypes of human Prader-Willi syndrome and Snord116del mouse
PWS feature Mouse feature or test Snord116 del mice Comparison
Growth and development
Growth delay/short stature Growth curve Severe growth retardation +
GH deficiency Liver Igf1 RNA for GH function Q +
Hypogonadism Morphology and histology of gonads Normal -
Delayed sexual maturation Time of vaginal opening in females to assess sexual
maturation
Delayed +
Infertility Fertility and litter size Normal -
Neurological features
Hypotonia Wire-hanging test and initial rotarod test for motor strength Normal -
Learning disability Rotarod test for motor learning Deficient +
Behavior disturbance, anxiety Elevated plus maze testing for fear and anxiety q +
Proficiency at jigsaw puzzles Y maze test for working memory and spatial memory Normal +
Insensitivity to pain Hot plate for nociception Normal -
Feeding and energy homeostasis
Hyperphagia, with onset at 2–6 yr Daily food intake Normal at 7 wk, hyperphagia after 3 mo +
Longer meal time Feeding bout duration q +
Obsession with food, lack appetite
control
Ability to adjust caloric intake level to high fat (HF) diet Normal -
24hr fasting and re-feeding Normal -
Obesity Long term weight gain on HF diet Resistant to obesity O
Measurement of body fat content Q O
Type II diabetes Glucose and insulin response F: Normal +
M: insulin sensitivityq O
Abnormal temperature regulation Core body temperature in cold Stable -
Elevated ghrelin Radioimmunoassay of plasma ghrelin level q +
+=concordant; -=discordant; O=phenotype deviates in opposite direction
doi:10.1371/journal.pone.0001709.t001
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pituitary rather than the hypothalamus [29]. Hypoplastic
pituitaries have occasionally been reported in patients. In the
Snord116del mice, we found normal pituitary development and
structure, with normal representation of all five specific hormone-
producing cell types. In comparison, in the lit/lit dwarf mice with a
mutation in the GHRH gene (GeneID: 14601), the anterior
pituitary is hypoplastic and GH-producing cells are reduced in
number and are abnormally distributed [38].
Individuals with PWS have hypogonadism due to insufficient
gonadotropin secretion, but their delayed puberty responds to GH
treatment, indicating that it may be caused in part by deficient GH
secretion [29]. The Snord116del females also have delayed puberty,
as observed by delayed vaginal opening, in the absence of other
signs of hypogonadism. We, therefore, propose that their delay in
adolescent growth as well as in sexual maturation may be due to a
defect in growth hormone release.
Neurobehavioral features
The diagnostic criteria of PWS include developmental delay,
cognitive impairment, and characteristic behavior problems such
as temper tantrums, obsessive-compulsive behavior and stubborn-
ness. In addition, a high pain threshold is noticed in many PWS
individuals [2]. The neurobehavioral tests of Snord116del mice
uncovered increased anxiety/fear in the elevated plus maze test, as
well as impaired motor learning in the rotarod test. The elevated
level of fear or anxiety may reflect higher stress level in the deletion
mice, which is consistent with reports in PWS subjects. Snord116del
mice responded as quickly to thermal pain as their WT littermates.
With respect to motor function, the mouse model differs from
the human disorder. In PWS subjects, motor milestones are
typically delayed by one to two years due to infantile central
hypotonia. Although muscle tone improves with age, deficits in
strength, coordination, balance, and motor planning may
continue. Growth hormone treatment, by increasing muscle mass,
can improve motor skills. In the Snord116 deletion mouse model,
we observed normal locomotor activity and excellent wire-hanging
ability. Although initially the deletion mice performed similarly or
even better than controls on the rotarod, they did not improve
upon training, indicating a motor learning deficiency in the
presence of good motor strength. Thus, we propose that in PWS
subjects, the motor deficit may not solely be due to hypotonia, but
an independent motor learning deficit may also be at play.
Energy homeostasis regulation and food seeking
behavior
What causes the hyperphagia and food-seeking behavior in
PWS is unknown. At least three non-exclusive theories have been
discussed. First, the hypothalamus, the center for energy
homeostasis, may be defective. Second, neuro-imaging studies of
PWS subjects indicated that the brain regions involved in reward
and motivation, such as amygdala and medial prefrontal cortex,
may be activated in the addiction-like food seeking behavior of
individuals with PWS [39,40]. Third, in studies of eating behavior,
PWS individuals had longer meal times [41–43] and were
insensitive to satiety signals [44]. We will now evaluate these
hypotheses in the light of the results of our studies,
In Snord116del mice, the energy homeostasis regulation was
normal under several testing conditions. First, the deletion mice
were able to reduce their total food intake in response to higher
caloric food and kept a more stable body weight than did WT
controls. Second, the deletion mice were able to compensate for
fasting with the same precision as the WT littermates, and that
distinguishes Snord116del mice from other genetic models of
obesity, such as ob/ob (leptin-null) mice, or those with hypotha-
lamic neuronal ablation [22]. Third, the deletion mice were able
to maintain their core body temperature in a 4uC environment, in
contrast to many obese mouse mutants, such as ob/ob, db/db (null
for leptin receptor), and stat3-/- mice, that quickly become
hypothermic in the cold [24,45]. Fourth, the Snord116 deletion
mice do not become obese even though the adults have increased
daily food intake compared to WT. As we found no evidence of a
deficiency in homeostasis regulation of food intake and energy
expenditure, we propose that the pathophysiology of PWS does
not involve a defect in energy homeostasis regulation, but rather,
in behavioral aspects of overeating. Mutant mice, however, must
have a way to maintain stable body weight despite their
hyperphagia, a mechanism apparently lacking in humans with
PWS.
Extensive studies on stress and feeding [46] indicate that
increased stress may lead to increased cortisol levels and to
increased feeding of palatable food. We considered the hypothesis
that elevated stress might be the cause for hyperphagia in PWS,
but found no evidence to support it. First, cortisol levels were
reportedly normal in PWS children [47]. Second, the hyperphagia
in PWS is not associated with seeking palatable food, but with a
craving for any food items, and when restricted, even from trash.
Third, during the first two days in the metabolic chamber, the WT
mice reduced their food intake and lost body weight, which is a
normal response to a stressful novel environment. The Snord116del
mice, however, showed attenuated feeding inhibition, suggesting
that their drive to feed overrides any fear and anxiety caused by
the novel environment. In summary, in both human PWS subjects
and our deletion mice, there is no evidence that increased levels of
anxiety or stress is the cause for hyperphagia.
Based on eating studies in humans, it was proposed that PWS is
a genetic model of starvation instead of food addiction [20].
Consistent with this proposal, PWS subjects do value food items
more than other objects. In a recent functional MRI study, PWS
individuals had higher activities of blood oxygen dependent
response to pictures of food than to pictures of animals or tools.
The signal was located in the medial pre-frontal region which is
known to mediate reward [40]. These PWS subjects had normal
insulin, glucose and triglyceride levels. Hence, the food seeking
behavior is not caused by energy insufficiency, but rather by an
abnormal response of the brain in the presence of sufficient fuel.
Consistent with this notion, the Snord116del mice did not lose as
much weight as the WT when their caloric intake was restricted.
Thus, energy insufficiency is not likely to cause their hyperphagia.
Studies comparing food intake behavior of young PWS
individuals and non-PWS obese controls showed that the PWS
group spent more time eating, and ate more food [41].
Furthermore, PWS subjects, on average, ate three times more
calories to attain a similar feeling of decreased hunger as did a lean
control group [42,48]. A detailed analysis of their eating behavior
revealed that PWS children had a slower initial eating rate, but a
much longer meal duration and non-decelerating eating curves
[43]. Our Snord116del mouse model recapitulates the abnormal
feeding behavior in human PWS. Their hyperphagia is associated
with prolonged meal time, indicating a delay in meal termination
that is most likely due to lack of sensing satiety.
Circulating neuropeptide hormones related to appetite regula-
tion were measured in PWS subjects, and while leptin levels were
similar to those in non-PWS obese subjects [49], plasma levels of
ghrelin were elevated in adults [50–52]. Ghrelin is produced
mostly in the stomach, and circulating levels are normally
increased by fasting and reduced after feeding. Increased density
of ghrelin-expressing cells was reported in PWS adult gastric
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Snord116del mice which replicates the human data. It could be
responsible for their hyperhagia, as in fed Snord116del animals, the
ghrelin level was more than two-fold higher than in fed WT
controls and resembled the fasting level in the WT mice.
It is puzzling that Snord116del mice eat more but retain a lean
body composition. The metabolic profile of Snord116del mice
showed decreased fat utilization, which is consistent with their
elevated plasma ghrelin levels, as ghrelin administration in rodents
leads to an increased respiratory quotient indicating less fat usage
[54]. Ghrelin administration in normal rodents does not change
energy expenditure, and, therefore, the ghrelin-induced decreased
fat utilization leads to increased adiposity. In the Snord116del mice,
however, energy expenditure is increased and body fat content is
reduced. Thus, the metabolic profile of Snord116del mice does not
recapitulate the effects of exogenous ghrelin administration.
Whether and how hyperghrelinemia causes hyperphagia in
PWS individuals and Snord116del mice remains an open question.
Since the gut hormone does not cross the blood-brain barrier in
mice[55], any relevance of the hyperghrelinemia for the
hypothalamic circuits that regulate feeding behavior is uncertain.
In human PWS subjects, a short-term clinical trial of somatostatin
treatment lowered plasma ghrelin level but failed to reduce
appetite [56]. These results are difficult to interpret because
somatostatin also suppresses the levels of anorexic peptides such as
peptide YY. Future work crossing Snord116del mice with ghrelin-
null mice and mice lacking the ghrelin receptor (also called growth
hormone secretagogue receptor, GHS-R, GeneID: 208188) may
define the role of ghrelin in the phenotype of Snord116del mice.
Why is Snord116 imprinted?
The function of imprinted genes in placental mammals is to
regulate the growth of fetal and placental tissues [57]. Imprinting is
thought to have evolved from a conflict between maternal and
paternal genomes for the allocation of maternal resources.
Paternally expressed genes promote growth (Igf2, Peg1, Peg3,
Ins1/2, Slc38a4), and experimental knock-out of these genes
restricts fetal and placental growth. Maternally expressed genes
have the opposite effect [58]. While the main site of this
intergenomic conflict is the placenta, we propose that the
paradigm may extend to neonatal life. During the period before
weaning, there is competition for maternal milk. Remarkably, the
Snord116del mice were of normal size at birth and were not
hypotonic, but failed to grow in the first three weeks of life, while
they were dependent on maternal milk. As soon as they were
weaned and eating on their own, their growth rate normalized. It
is, therefore, possible that the primary function of the Snord116
snoRNA is to promote postnatal growth during the pre-weaning
period. PWS infants also fail to thrive during this time, even when
nutrition is normalized via tube feeding. The ‘‘failure-to-thrive’’
condition may signal to the brain a state of starvation [20]. In
response, the appetite regulatory circuits may become wired in
such a way that the ‘‘lack-of-satiety’’ signal is permanently on and
leads, in some unexplored way, to hyperghrelinemia and mealtime
extension.
Not all imprinted genes can be functionally linked to the conflict
hypothesis [59]. But not all genes in an imprinted domain need to
be targets of this evolutionary selection; some could be bystanders,
if imprinting is a genomic domain phenomenon. The functions of
SNRPN and NDN do not fit well with the conflict hypothesis.
Neither do the functions of the distal-less homeobox genes DLX5
and DLX6 whose imprinting status has recently been refuted [60].
Therefore, we propose that the intronic snoRNA cluster, rather
than the SNRPN-protein coding part of the large transcript, or
other genes such as NDN, is the target of selection for imprinted
paternal expression of the 15q11.2 genomic domain.
Conclusions
The Snord116 mouse model provides a novel system to study the
mechanism of hyperphagic behavior, and to test potential
therapeutic interventions. Our studies of feeding behavior indicate
that the meal size, as determined by the length of feeding bouts
reflecting meal termination, is the key to the hyperphagic
behavior, while energy homeostasis control is normal. This
distinguishes the Snord116del mouse model from the genetic mouse
models of obesity, including ob/ob, db/db, Sim1 haploinsufficiency
[61], Mc4r deletion [62] and others [63] that lack proper
homeostasis control.
We propose that the primary mechanism for hyperphagia in
PWS is not a defect in the energy homeostasis control, but in
sensing satiety, and that higher cognitive regions of the brain, such
as the medial prefrontal cortex, which is involved in interpreting
incentive values of food, and those involved in planning
complicated schemes to obtain food, may be changed secondary
to the prolonged perception of hunger/lack of satiety. With respect
to developing rational therapeutic interventions, we expect that
drugs used for correcting addiction, which target the incentive
control mechanisms in brain, will not be effective, and that
research must focus on the sense of satiety required for meal
termination. Since healthy lean individuals decelerated their rate
of food intake within minutes from the start of a meal [43], meal
termination is likely caused by a response to pre-absorptive cues.
The Snord116del mice and PWS individuals may have a deficiency
in sensing satiety signals pre-absorptively, such as vagal afferent
nerve signals that transmit gastrointestinal distention, oral sensory
input, and neuroendocrine peptides secreted directly by the
gastrointestinal tract in response to distention.
From the genetic and mechanistic point of view, the most
important next step is the identification of the target RNA(s) of
Snord116 and of the type of modification it catalyzes. Recognizing
the involvement of a non-coding RNA in postnatal growth and
appetite control represents the novel aspect of our work. The
mouse model we created will allow future investigations into the
mechanisms of early postnatal growth regulation, adult-onset
hyperphagic behavior and metabolic adjustments that allow the
mice to remain lean in the presence of hyperphagia with normal
energy homeostasis,
Materials and Methods
Generation of targeting constructs
Upstream targeting construct. A9k bStuI-BstEII fragment
was cloned from BAC RP23-371M8 (GenBank accession #
AC026679, sequence antisense 125827-117210) and a 2 kb
cassette containing a loxP site, and a PGK-Neo gene flanked by
Frt1 sites (59-GAAGTTCCTATTCTCTAGAAAGTATAGGA-
ACTTC-39) was subcloned into the PacI site (AC026679, position
121632), which is ,4 kb downstream of Snord64. A 1.2 kb BamHI-
EcoRI fragment of a PGK-diphtheria toxin cassette was purified
from pBC-KS.DT7 (courtesy of Colin Stewart) and inserted
downstream into the 9 kb genomic fragment. The finished
construct was linearized before transfection.
Downstream targeting construct. A 7.4 kb EcoRV-MfeI
fragment was cloned from BAC RP23-309E15 (GenBank acces-
sion # AC026683, sequence 90280-98899). A cassette with
puromycin resistance and thymidine kinase selective markers
was constructed with flanking Frt5 sites (59-GAAGTTCCTA-
TTCTTCAAAAGGTATAGGAACTTC-39) [64,65], and a loxP
site, and was subcloned into the BsrDI site (AC026683. position
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1.2 kb BamHI-EcoRI fragment of a PGK-diphtheria toxin cassette
was purified from pBC-KS.DT7 and cloned into the construct
downstream of the genomic fragment. The finished construct was
linearized before transfection.
Generation of doubly-targeted (2-loxP) and deletion (1-
loxP) ES cells
Generation of doubly-targeted (2-loxP) ES cells. BRUCE4
ES cells derived from C57BL/6 mice were a gift from Colin
Stewart [66]. They were first transfected with the upstream
targeting construct and placed in selection medium containing
200 mg/ml G418 (Invitrogen). DNA from resistant colonies was
tested by Southern blot. First, the DNA was digested with NcoI and
probed with probe UR, a 1.8 kb BstXI fragment (AC026679,
position 113455-115280) located downstream of the targeted
region. The wildtype allele is represented by a 19.5 kb fragment,
and the recombinant allele by a 12 kb fragment. The positive
clones were subjected to a second Southern blot assay with probe
UL, a PCR fragment (AC026679, position 128857–127788)
located upstream of the targeted region. After NcoI digestion, the
WT band is 19.5 kb and the recombinant band is 9.5 kb. Of 192
clones analyzed, only one clone (B41) passed both tests.
ES clone B41 was then transfected with the downstream
targeting construct. Colonies resistant to selection in medium
containing 1.5 mg/ml puromycin (Invitrogen) were tested by
Southern blot assay for homologous recombination. First, the
DNA from resistant clones were digested by PstI and probed with
probe DR (an MfeI fragment of AC026683, position 98899-99822)
located downstream of the targeted region. The WT allele
generates a band of .16 kb and the recombinant allele a
fragment of 6.5 kb. Next, the positive clones were subjected to a
second Southern blot assay of XmaI digestion and hybridization to
probe DL (AC026683, position 89169-89990), residing upstream
of the targeted region. The WT XmaI fragment is 14 kb and the
recombinant fragment is 8 kb. Of 96 colonies tested, 9 with good
morphology passed both tests, and were labeled C1-C9.
To remove the Neo
r and Puro
r-TK selective markers, the
doubly targeted clone C3 was transfected with the FLP
recombinase expression vector, pCAGGS-FLPe[67] and then
grown in medium containing 0.2 mM FIAU (Moravek, CA) to
select against TK activity. Cells were genotyped by a PCR assay
(see below). Of 192 colonies tested, 43 were positive (E1–E43).
Generation of deletion (1-loxP) ES cells. Deletion (1-loxP)
ES cells were generated by transfecting doubly targeted (2-loxP)
ES cell clone C3 with a Cre recombinase expression vector
pBS185 (Invitrogen) to induce recombination between the loxP
sites that removed ,150 kb sequence. The cells were selected in
medium containing 0.2 mM FIAU (Moravek, CA). DNA from
surviving colonies was tested by Southern blot using probe UL
after NcoI digestion. The sizes of NcoI fragments representing the
different alleles are: WT 19.5 kb, 2-loxP cells 9.5 kb, and 1-loxP
cells 13.5 kb. The clones were also tested after StuI digestion with
probe DR. The fragment sizes are: WT.16 kb, 2-loxP cells 6.5kb,
and 1-loxP cells 10 kb. A total of 14 positive clones (D1-D14) were
obtained from 300 clones. They were all verified by the PCR
genotyping assay.
Genotyping by PCR
For genotyping 1-loxP ES cells and mice, we used primers
PA (59-TTTACGGTACATGACAGCACTCAAG, AC026679
position 121766-121742), PC (59-AATCCCCAACCTACTT-
CAAACAGTC, AC026683 position 94254-94278) and PD (59-
TGGATCTCTCCTTGCTTGTTTTCTC, AC026683 position
94688-94664). The WT allele produces a PCR product of 435 bp
with primers PC and PD, but no product with PA and PD since
the distance between these primers is ,150 kb. After CRE-
induced deletion, primers PA and PD generate a product of
337 bp. PCR was performed using Taq polymerase (Promega)
with 1.5 mM MgCl2, and the following cycling conditions: 95uC
for 3 min; then 35 cycles of 95uC for 20 sec, annealing at 60uC for
20 sec, extension at 72uC for 90 sec; followed by a final extension
at 72uC for 5 min, and cooling at 4uC.
For genotyping 2-loxP cells, we designed two sets of primers to
test for the junctions in upstream and downstream targeted
regions. In the upstream targeted region, PCR with primers PA
and PB (59-CATGCCAATGGTAAATCGTGG, AC026679 po-
sition 121388-121368) generates a 399 bp product of the WT
allele; and no product of the doubly targeted allele in clones C1-
C3 under the above cycling conditions, for the primers are
separated by the 2 kb Neo
r marker. After FLP-induced deletion, a
PCR product of 500 bp is generated. In the downstream targeted
region, PCR with primers PC and PD produces a 435 bp product
of the WT allele. In the doubly targeted allele in clones C1-C3, PC
and PD are 4 kb apart and no PCR product is generated using the
above conditions. After FLP-induced recombination, a PCR
product of 510 bp is generated.
Derivation of mice from targeted ES cells
We used albino C57BL/6J–Tyr
c-2J/J mice (The Jackson Labora-
tory, stock #000058) as the donor of host blastocysts. We obtained
three chimeric mice from E3 (derived from C3) 2-loxP ES cells with
20–80% black coat color, and all of them transmitted the modified
allele through the germ-line with more than 50% offspring derived
from ES cells. The 2-loxP heterozygous mice were mated with
homozygous C57BL/6-Tg(Zp3-cre)93Knw/J mice ((The Jackson
laboratory, stock #003651). Doubly heterozygous (2-loxP/+;Z p 3 -
Cre/+) females were mated with WT C57BL/6J males to obtained
1-loxP mice in the next generation. We also obtained two chimeric
mice from injection of 1-loxP ES cells (clone D6) with 10% and 40%
black coat color. Only the one with 40% chimeric color passed
the deletion allele through the germ-line. Both 2-lox and 1-lox
mice will be available from The Jackson Laboratory (the 2-loxP, the
floxed conditional strain, C57BL/6-Snord116
tm1Uta/J under stock
# JR8118, and the 1-loxP, the targeted mutation, knock out,
C57BL/6-Snord116
tm1.1Uta/J under stock # JR8149.
Quantitative RT-PCR Assays
RNA was isolated from brain and liver by using RNA STAT60
(Tel test) following manufacturer’s instruction. RNA was
treated with 0.5 U RNase-free DNase I (Ambion) for each mgo f
RNA at 37uC for 30 min, and was purified by phenol-chloroform
extraction and precipitated with ethanol. Reverse transcription
reactions were done using M-MLV reverse transcriptase (NEB)
following manufacturer’s instruction. For each 20 ml reaction,
2 mg of RNA was used. The RT reactions were diluted 1:25,
and 2–5 ml of diluted reaction was used for quantitative PCR
using the 26 polymerase mix (Applied Biosystem) in a 25 ml
reaction, with 1 ml of 5 mM of each primers. We used a ABI 5700
real-time PCR machine. The primers for real-time quantitative
PCR are: Ndn-F (59-GCACCTGAGGCTGACCAATC) and Ndn-
R( 5 9-CATGGGCATACGGTTGTTGAG); Snrpn-F (59-TGC-
TACGTGGGGAGAACTTG) and Snrpn-R (59-CCTGGGGAA-
TAGGTACACCTG); Snord107-F (59-GATGATATAGGACCT-
TGTCTG) and Snord107-R (59-GATTTCAGTCACTGT AAG-
CTC); Snord116-F (59-TGGATCTATGATGATTCCCAG) and
Snord116-R (59-TGGACCTCAGTTCCG ATGAG); Snord115-F
(59-GGGTCAATGATGACAACCCAATG) and Snord115-R (59-
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CACTGGTCCGGCTAGAG) and Ube3a-R (59-TTCAAGTC-
TGCAGGATTTTCCA) [68]; Gapdh-F (59-CTCCACTCACGG-
CAAATTCA) and Gapdh-R (59-ATGGGCTTCCCGTTGAT-
GA); Igf1-F (59-GCTGGTGGATGCTCTTCAGTT) and Igf1-R
(59-GGTGCCCTCCGAATGCT) [69].
Measurement of serum IGF-I levels by enzyme-linked
immunosorbent assay (ELISA)
The procedures were carried out as described[70]. Monoclonal
hamster anti-mouse IGF-I antibody (catalog # MAB 791),
recombinant DNA-derived IGF-I (catalog #791) and biotinylated
goat anti-mouse IGF-I antibody (catalog #BAF 791) were
obtained from R&D Systems (Minneapolis, MN). Microtiter plates
(96-well) were coated with purified monoclonal hamster anti-
mouse IGF-I antibody at 0.5 mg/well in 100 ml of phosphate-
buffered saline, incubated overnight at room temperature on a
shaker, then washed three times with 300 ml/well wash buffer
(PBS, 0.05% Tween-20), followed by 1 hr incubation with 300 ml/
well blocking buffer (PBS, 5% Tween 20, 5% sucrose, 0.05%
sodium azide) and three final washes with wash buffer. Standards
were prepared by diluting recombinant DNA derived IGF-I in
assay buffer (50 mM sodium phosphate, 150 mM NaCl, 0.1%
Tween 20, 0.25% bovine serum albumin, pH 7.4) in concentra-
tions ranging from 0 to 25 ng/ml.
Prior to IGF-I assay, 0.1 ml acid/ethanol reagent (12.5% 2 N
HCl, 87.5% ethanol, v/v) was added to 0.025 ml of each serum
sample. The mixture was incubated at room temperature for
30 min, microcentrifuged at 10,000 g for 10 min, and 0.05 ml
supernatant was neutralized with 0.025 ml 1 M Tris base and
diluted with IGF-I assay buffer to a final dilution of 40–100 fold.
For the acid–ethanol extraction procedure, recovery of added
mouse IGF-I was .90%. Standards, controls or prepared samples
(50 ml/well) and 50 ng/well (50 ml/well) biotinylated goat anti-
mouse IGF-I antibody were added to the prepared assay plates
and incubated at room temperature for 2 hr on a shaker. Wells
were then washed three times with wash buffer, followed by
addition of 100 ml/well of Streptavidin–horseradish peroxidase
(HRP) conjugate (Pierce Chemicals, Rockford, IL) and further
incubated for 20 min at room temperature. After 4 washes with
wash buffer, 100 ml/well of o-phenylenediamine hydrochloride
(OPD) at 1 mg/ml in hydrogen peroxide Substrate (Pierce
Chemicals) was added to each well and incubated for an additional
10–20 min. The reaction was stopped by the addition of 50 ml/
well 2 N H2SO4 and absorbance was determined on a plate
spectrophotometer (Molecular Designs, Sunnyvale, CA) at
490 nm.
Neurobehavioral tests
All mice were housed in a facility with 12 hr light/dark cycles
(lights on 7 am–7 pm). For all the neurobehavioral tests, only male
mice were used. They were acclimated to the test room for more
than 1 hr, and the tests were done between 8 am and 6 pm.
Open field test. The testing chamber is constructed of a
plexiglass box of 48 cm648 cm626 cm, and the floor is divided
equally into 16 squares. A center area of 12 cm612 cm is labeled
with red marker. Each mouse was given 5 min to explore the field
and was video taped. The number of squares through which the
mice traveled (3 paw entry), time spent in the inner square (2 paw
entry), time spent in rearing and grooming were read from the
video.
Elevated plus maze test. All mice were pre-handled at least
once a day for 5 days before the tests. The maze was constructed
with gray plexiglass. The four arms are 29 cm long and 5 cm
wide. The open arms have 0.5 cm-wide edges that are 1 mm high
to prevent mice from sliding off the arms. The closed arms have
walls of 29 cm629 cm with a dead end. The maze was elevated
50 cm above ground. The test mouse was placed at the center of
the maze and given 5 min to explore. Activity was recorded on
videotape for later analysis.
Y maze test. The Y maze was made from white plexiglass
with three identical arms. Each arm is 30 cm610 cm610 cm. In
the spontaneous alternation test, the test mouse was placed at the
end of one arm and was given 7 min to explore. The starting arm
for each mouse was randomized. The sequence of entry into each
arm was recorded. All mice were pre-handled at least once a day
for 5 days before the tests. In the novel arm exploration test, the
maze was floored with soiled beddings, and one arm was blocked
with a door. A mouse was placed in the end of one arm and was
allowed to explore for 5 min. The bedding was stirred before each
test. After 45 minutes, the third arm was opened, and the bedding
was stirred and evenly distributed into all three arms. A mouse was
placed in the same starting arm and was allowed 5 min to explore
the three arms. Time spent in each arm and numbers of entries
into each arm were recorded.
Wire-hanging test. A metal grid of 12 cm616 cm, with bars
spaced every 8.5 mm was hung 50 cm above the floor. Multiple
layers of absorption pads were used as a cushion to catch the
falling mouse. The test mouse was placed onto the grid and the
grid was turned upside down. With the observation period of
150 sec, the latency to fall was recorded.
Rotarod test. The Columbus Economix (Columbus, Ohio)
machine with eight tracks was used. All mice were pre-handled at
least once a day for five days before the tests. The mice were given
three trials of 90 sec on the rotarod at constant speed of 3 rpm to
become familiar with the equipment. Afterwards, they were
exposed to a 6 min trial with constant acceleration from 3 rpm to
45 rpm. Two trials with one hour interval were given on each day
for 6 consecutive days. The time on top is defined as the time until
the mouse either falls off the wheel or wraps around the wheel with
passive rotation.
Hot plate test. A thermal metal block of 16 cm69.5 cm was
preheatedto52.5uC.Thetestmousewasplacedonthemetalsurface
and video taped. When it licked its hind paws or jumped, or the
maximum time of 30 sec had elapsed, the mouse was removed from
the hot plate. The video was analyzed at 46slow-play mode.
Feeding and energy homeostasis studies
Food intake measurement. Mice were individually housed
for one week. They were switched to new cages with water and
two pieces of food pellets. The food pellets were weighed within
1 hr after the onset of the light cycle, and 1 hr before the onset of
the dark cycle. Regular rodent chow (Prolab 3000, 3.0 kcal/g;
calories from carbohydrates: fat: protein=60:14:26) was used if
not specified. For high fat diet, we used HFD Research Diet
D12451 (4.73 kcal/g; calories from carbohydrates: fat:
protein=35:45:20). For the fasting study, the mice were fasted
for 24 hr with free access to water.
Core temperature in cold. The core temperature was
measured with an anal thermometer (BAT-12, Ploytemp
Instrument, NJ). The mice were placed into pre-cooled cages
with food and water in a 4uC room, and their core temperature
was measured every 30–60 min.
Body fat content measurement. The mice were
anesthetized with 0.25% Avertin at a dose of 12 ml/g weight
and were placed on the GE Lunar Piximus II densitometer using
dual energy x-ray absorptiometry (DEXA) to measure body
composition.
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Tolerance Test (GTT), the mice were fasted for 16 hr (6 pm–10
am), and then injected i.p. with 10% D-glucose solution at a dose
of 1 g/kg weight. The blood glucose concentration was measured
with a glucometer (Ascensia Elite, Bayer) at 0, 30, 60, 90 and
120 min. For the Insulin Tolerance Test (ITT), the mice were
fasted for 4 hr (7 am–11 am), and then injected i.p. with
recombinant insulin (Humulin, Eli Lily), and their blood glucose
levels were measured as above. Different doses of insulin were used
to obtain a maximum response without the mice passing out due
to extreme hypoglycemia: males on chow, 1.6 U/kg; males on
high fat diet, 2.0 U/kg; females on chow and on high fat diet,
1.0 U/kg.
Metabolic chamber study. Mice were placed into Oxymax
System metabolic chambers (Columbus Instruments International
Corporation, Columbus, OH) with water and food (rodent chow).
Their locomotion, food and water intake, O2 consumption and
CO2 emission were automatically monitored. RER (Respiratory
Exchange Rate, also known as RQ) was calculated as VCO2/
VO2.
Ghrelin measurement. Plasma was prepared from tail
blood collected into ice-cold tubes with EDTA (final
concentration 1mM) and protease inhibitor cocktail (Roche)
between noon and 3 pm from 11 months old male mice with ad
libitum access to food and water, or after 24 hr food restriction.
Rat/mouse Ghrelin RIA kit (Phoenix Peptide, Belmont, CA) was
used to determine ghrelin level.
Statistical Analysis
Unless otherwise specified, all the data are expressed as
mean6standard error of the mean. The P values were calculated
using two-tailed t-test.
Supporting Information
Figure S1 Immunohistochemical detection of pituitary hormone
producing cells. On pituitary sections, all five pituitary hormone-
producing cell types show normal abundance and appearance in
Snord116del mice (Del) compared to WT littermates. a. Growth
hormone labeling of somatotrophs in E18.5 pituitaries at 56
magnification. b. Hormone staining at 636 magnification:
Thyroid stimulating hormone b subunit (TSHb) labels thyro-
trophs, Pro-opiomelanocortin (POMC) labels corticotrophs in the
anterior pituitary (AP) and melanotrophs in the intermediate lobe
(indicated by the arrows), and luteinizing hormone b subunit
(LHb) labels gonadotrophs in pituitaries of E18.5 embryos. PRL,
prolactin labels lactotrophs in 4-wk old pituitaries.
Found at: doi:10.1371/journal.pone.0001709.s001 (7.75 MB TIF)
Figure S2 Locomotion activity is not changed in mutant mice.
The same group of mice as in Figures 6 A, B, C and D, were
continuously monitored during 7 days in the metabolic chamber.
No significant differences between Snord116del and WT mice
were observed. Light and dark cycles are indicated on the
horizontal axis. The vertical axis represents the locomotion activity
per hour as measured by the numbers of infra-red beams the mice
crossed in the metabolic chamber.
Found at: doi:10.1371/journal.pone.0001709.s002 (0.61 MB EPS)
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